Entity Common Stock, Shares Outstanding of Adaptive Biotechnologies Corp from 31 Jul 2019 to 20 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Adaptive Biotechnologies Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2019 to 20 Feb 2026.
  • Adaptive Biotechnologies Corp Entity Common Stock, Shares Outstanding for the quarter ending 20 Feb 2026 was 153,981,561, a 1.4% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Adaptive Biotechnologies Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 153,981,561 +2,064,839 +1.4% 20 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 152,665,188 +5,085,702 +3.4% 31 Oct 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 152,273,915 +4,801,714 +3.3% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 151,916,722 +4,548,398 +3.1% 24 Apr 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 147,579,486 +2,806,735 +1.9% 04 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 147,472,201 +2,827,083 +2% 29 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 147,368,324 +3,057,324 +2.1% 02 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 144,772,751 +1,760,594 +1.2% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 144,645,118 +1,772,130 +1.2% 28 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 144,311,000 +2,083,048 +1.5% 28 Apr 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 143,226,757 +1,643,037 +1.2% 09 Feb 2023 10-K 14 Feb 2023 2022 FY
Q3 2022 143,012,157 +1,880,313 +1.3% 28 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 142,872,988 +2,107,139 +1.5% 29 Jul 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 142,227,952 +1,916,811 +1.4% 29 Apr 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 141,583,720 10 Feb 2022 10-K 15 Feb 2022 2021 FY
Q3 2021 141,131,844 +4,359,427 +3.2% 29 Oct 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 140,765,849 +4,972,121 +3.7% 30 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 140,311,141 +13,423,535 +11% 30 Apr 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 136,772,417 +12,433,359 +10% 31 Oct 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 135,793,728 +11,505,736 +9.3% 31 Jul 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 126,887,606 30 Apr 2020 10-Q 12 May 2020 2020 Q1
Q3 2019 124,339,058 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 124,287,992 31 Jul 2019 10-Q 13 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.